Remove Medicine Remove Pharmacy Remove Sales
article thumbnail

Centre puts onus on SLAs to take action against e-pharmacies for violation of D&C Act and Rules

AuroBlog - Aurous Healthcare Clinical Trials blog

With the chemists and druggists across the country opposing the sale of drugs through online, the Central government is taking a stand that the sale of medicines should be strictly under the provisions of the existing regulations and the State Licensing Authorities (SLAs) are legally empowered to act against violation of the legal provisions.

Pharmacy 188
article thumbnail

MHRA bans OTC sale of codeine after recreational abuse reports

Pharmaceutical Technology

Codeine linctus has been reclassified from a pharmacy-only medicine to a prescription-only medicine in the UK.

Sales 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

pharmaphorum

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. So, suddenly, you’re unable to get the medicine you need and have been prescribed by a doctor.

Pharmacy 138
article thumbnail

China Opens the Door to Personal Medicine Imports and Third-Party Online Platform Sales

Pharmacy Checkers

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! The law does not relate specifically to “online pharmacies.”

Sales 64
article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. ” The post Supply chain middlemen ‘pocket half of US branded medicine spending’ appeared first on. .

Branding 111
article thumbnail

Master the Hidden Economics of Pharmaceuticals—In Under an Hour—with DCI's New eLearning Modules

Drug Channels

You'll learn how money and medicines move between manufacturers, wholesalers, pharmacies, PBMs, and payersand how each relationship affects costs and outcomes. The Economics of Retail, Mail, and Specialty Pharmacies Gain a clear-eyed view of how different pharmacy channels generate revenue and manage costs.

article thumbnail

FTC launches probe into pharmacy benefit management sector

pharmaphorum

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). — FTC (@FTC) June 7, 2022.